TY  - CONF

T1  - Development of an AAV9-mediated gene therapy for hereditary spastic paraplegia 47

JO  - HUMAN GENE THERAPY

PY  - 2019/01/01

AU  - Scarrott JM

AU  - Coldicott I

AU  - Davies A

AU  - Hirst J

AU  - Karyka E

AU  - Bauer C

AU  - Azzouz M

ED  - 

VL  - 30

IS  - 8

SP  - A18

EP  - A18

Y2  - 2024/12/22

ER  -